Stockholders’ Loans (Details Narrative) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 06, 2018 |
Mar. 31, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
2015 Loans [Member] | ||||
Short-Term Debt [Line Items] | ||||
Debt instrument interest rate | 2.42% | 2.45% | ||
Terms of agreement description | Under the original loan terms, the aggregate loan amount is payable to the lenders by the Company only upon the approval of the Company’s board of directors that the Company’s profits reached an amount of US$ 0.5 million and upon such terms and in such installments as shall be determined by the Company’s board of directors | |||
Debt instrument carrying amount | $ 34 | $ 37 | ||
2015 Loans [Member] | Board of Directors Chairman [Member] | ||||
Short-Term Debt [Line Items] | ||||
Payments for loans | $ 500 | |||
2017 loans [Member] | ||||
Short-Term Debt [Line Items] | ||||
Debt instrument interest rate | 2.42% | 2.45% | ||
Terms of agreement description | Under the original loan terms, the aggregate loan amount are repayable by the Company upon the closing of an investment in the Company with proceeds greater than US$ 500 thousand | |||
Debt instrument carrying amount | $ 4 | $ 4 | ||
Debt instrument maturity date | Dec. 31, 2023 | |||
2018 CLA [Member] | ||||
Short-Term Debt [Line Items] | ||||
Terms of agreement description | In case of an Exit event, as described in the 2018 CLA, the loan and all accrued interest will be either converted to shares or repaid at 200% of the outstanding amount all as per the Majority lenders decision | |||
Debt instrument carrying amount | $ 124 | 136 | ||
Debt instrument maturity date | Dec. 31, 2023 | |||
Debt instrument interest rate terms | In accordance with 2018 CLA, the loan bears interest at a rate per annum equal to three percent (3%) compounded and accrued annually, and was originally repayable on December 31, 2018, or later date as determined by the shareholders representing more than 80% of IR. Med Ltd.’s issued and outstanding shares who has also provided loans with terms similar to the terms of the agreement (‘Majority Lenders”), unless earlier converted to shares | |||
Financing expenses on loan | $ 5 | $ 5 |